Infusion Systems Market Analysis

ID: MRFR/MED/0703-CR

168 Pages

Kinjoll Dey

May 2017

Infusion System Market Research Report By Product Type (Iv Disposable, Infusion Pump, Others); By Application (Chemotherapy, Diabetes, Gastrointestinal Diseases, Pediatrics, And Others); By End User (Hospitals, Specialty Oncology Wards, Homecare) - Forecast To 2035

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Download PDF

Market Analysis

In-depth Analysis of Infusion Systems Market Industry Landscape

The important part of the healthcare business called the "Infusion Systems Market" is going through big changes because of new technologies, more people getting chronic diseases, and an older population. One trend that stands out is the rise in demand for home IV treatment, which is driven by patients' needs for ease and low costs. Because of this change, companies are focused on making infusion devices that are easy for people to use and can be taken with them. The market is changing all the time because of new technologies. For example, smart infusion systems and devices offer better accuracy, communication, and data tracking. Putting IoT and digital health solutions together is improving patient results and making healthcare service more efficient. More and more people are getting chronic diseases like cancer and diabetes, which is driving up the demand for infusion systems. Infusion devices are very important for making sure that drugs are delivered precisely and safely to people who need long-term medicine management. Key players in the infusion systems market are increasingly merging and buying each other out as a way to stay competitive. This trend aims to improve product lines, reach more customers, and encourage new ideas by getting people to work together. A big thing that affects how markets work is the governing environment. Tough rules and laws for medical equipment, like IV systems, are making companies spend money on research and development to make sure they meet the rules and make sure their products are safe. The growing number of older people around the world is making more people want infusion devices, since older people often need long-term medical care. This change in the population is affecting market growth, with a focus on making treatment solutions that are age-appropriate and patient-centered. There are now cheaper options on the market, like reuse infusion systems, that are meant to answer worries about cost while still meeting quality and safety standards. This trend is especially important in places where finding affordable health care is very important. A focus on the patient is becoming more important in the planning and creation of infusion devices. Manufacturers are making devices easier to use by adding user-friendly displays, reducing device complexity, and improving the overall patient experience. This is done to help patients stick to their treatment plans. The world market for infusion devices is growing, with a focus on economies that are still growing. The market is growing because more people are learning about healthcare, infrastructure is getting better, and people's spending incomes are going up. This gives market players new possibilities. The market is growing in line with improving technology, more people requiring long-term treatments, and the evolving healthcare system. Players in the market need to change with these changes to stay competitive and meet the changing needs of both consumers and healthcare workers.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

The global infusion system market is projected to grow from 5.49 USD billion in 2024 to 16.5 USD billion by 2032, reflecting a robust growth trajectory.

Key Market Trends & Highlights

Infusion System Key Trends and Highlights

The market is expected to experience a compound annual growth rate of 10.55 percent from 2025 to 2032.
By 2035, the infusion system market is anticipated to reach a valuation of 16.5 USD billion.
In 2024, the market is valued at 5.49 USD billion, indicating a substantial increase over the forecast period.
Growing adoption of advanced infusion technologies due to the increasing prevalence of chronic diseases is a major market driver.

Infusion Systems Market

CAGR

10.55%

Market Size & Forecast

2024 Market Size	5.49 (USD Billion)
2035 Market Size	16.5 (USD Billion)
CAGR (2025-2035)	10.55%
Largest Regional Market Share in 2024	latin_america)

Major Players

Becton Dickinson and Company (US), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Fresenius Kabi (Germany), ICU Medical, Inc. (US), Medtronic plc (Ireland), Moog Inc. (US), Smiths Medical (US), Terumo Corporation (Japan), NIPRO Corporation (Japan), Avanos Medical, Inc. (US), Tandem Diabetes Care, Inc. (US), JMS Co., Ltd. (Japan), Insulet Corporation (US), Roche Diagnostics (Switzerland), Zyno Medical (US), Teleflex, Inc. (US), Mindray Medical International Limited (China), Micrel Medical Devices SA (Greece), Ypsomed Holding AG (Switzerland)

Market Trends

Drivers

The rising incidence of cardiovascular diseases and chronic diseases leading to diabetes are the major factors that are driving the growth of the global infusion system market during the forecast period 2020 to 2025. Moreover, the rising patients of with diabetes and their adaptation to different types of infusion pumps are raising the demands for the infusion system market during the forecast period.

Opportunities

The benefit of the intravenous infusion system in administering medication, amino acids, minerals, and several essential micronutrients can create opportunities infusion system market by adding to the infusion for collateral nutrition. Smart infusion systems are technologically advanced with automation, drug libraries, operators, and the safety features for accurate and precise results of patients, it also helps in delivering controlled fluids into the patient systems.

Restraints

The improper disposable infusion pumps and the rising concerns about the safety of patients are leading to create several consequences and unmet needs of medical in the low-income countries are likely to hamper the growth of the global infusion system market.

ChallengesThe stringent regulation of governments for launching new device approval is the major factor that is restraining the infusion systems market during the forecast period 2020 to 2025. Furthermost, the U.S Foods and Drugs Administration has written a letter to the manufacturers of infusion systems where they are describing the problems related to the controlled release infusion system which serves as a major setback for the growth of the global infusion system market.Cumulative Growth AnalysisNorth America is predicted to rule the major drug infusion market size due to the rapid rise in the technological advancement of the developed countries.

North America is predicted to influence USD 3.49 Billion by the end of the year 2023.Value Chain AnalysisAccording to the latest report, the global infusion system market has been segmented on the basis of product type which comprises IV disposable, infusion pump, and others. IV disposable accounts for the maximum market share of the total market revenue in 2016. On the basis of application, the global infusion system market has been segmented into gastrointestinal diseases, chemotherapy, diabetes, pediatrics, and others.

The chemotherapy segment accounts for the maximum infusion system share of the total market in the year 2016.On the basis of end-users, the global infusion system market has been segmented into specialist oncology wards, hospitals, homecare, others. A hospital segment is expected to dominate the global infusion system market with the maximum market share in the year 2016.

The ongoing advancements in infusion technology appear to enhance patient safety and treatment efficacy, reflecting a growing emphasis on precision medicine in healthcare delivery.

U.S. Food and Drug Administration (FDA)

Infusion Systems Market Market Drivers

Market Growth Projections

Rising Healthcare Expenditure

Healthcare expenditure continues to rise globally, influencing the Global Infusion System Market Industry. Increased investment in healthcare infrastructure and services leads to enhanced access to advanced medical technologies, including infusion systems. Governments and private sectors are allocating substantial resources to improve healthcare delivery, which in turn drives the demand for effective infusion solutions. As healthcare systems evolve, the focus on patient-centered care and efficient treatment modalities becomes paramount. This trend is likely to sustain the market's growth trajectory, as stakeholders prioritize investments in innovative infusion technologies to meet the growing healthcare demands.

Regulatory Support and Standards

Regulatory bodies play a pivotal role in shaping the Global Infusion System Market Industry. The establishment of stringent safety and efficacy standards for infusion devices ensures that only high-quality products reach the market. This regulatory support fosters innovation and encourages manufacturers to develop advanced infusion systems that meet evolving healthcare needs. Compliance with these regulations not only enhances patient safety but also builds trust among healthcare providers and patients. As the market continues to expand, the emphasis on regulatory compliance will likely drive the development of safer and more effective infusion technologies.

Rising Prevalence of Chronic Diseases

The Global Infusion System Market Industry is witnessing a surge in demand due to the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders. As of 2024, the market is valued at approximately 5.49 USD Billion, reflecting the urgent need for effective treatment options. Infusion systems play a crucial role in managing these conditions, providing precise medication delivery and improving patient outcomes. The growing aging population further exacerbates this trend, as older individuals are more susceptible to chronic illnesses. This demographic shift suggests that the market will continue to expand, driven by the need for advanced infusion technologies.

Technological Advancements in Infusion Systems

Technological innovations are significantly shaping the Global Infusion System Market Industry. The introduction of smart infusion pumps, which offer features like dose error reduction systems and wireless connectivity, enhances patient safety and treatment efficacy. These advancements are likely to increase the adoption of infusion systems across healthcare settings. The market is projected to grow at a compound annual growth rate of 10.55% from 2025 to 2035, indicating a robust demand for these technologies. As healthcare providers seek to improve operational efficiency and patient care, the integration of advanced technologies into infusion systems becomes increasingly vital.

Increasing Demand for Home Healthcare Solutions

The Global Infusion System Market Industry is experiencing a notable shift towards home healthcare solutions. Patients are increasingly opting for home-based treatments due to the convenience and comfort they offer. Infusion systems designed for home use enable patients to receive necessary therapies without frequent hospital visits. This trend is particularly relevant for chronic disease management, where continuous treatment is essential. As the market evolves, the demand for portable and user-friendly infusion devices is expected to rise, contributing to the overall market growth. The projected market value of 16.5 USD Billion by 2035 underscores the potential of this segment.

Market Segment Insights

Infusion System Application Insights

Based on the application, the market is segmented into oncology, gastrointestinal diseases, cardiology, and musculoskeletal disorders.

Infusion System End-Users Insights

Based on the propulsion types, the market is segmented into diagnostic centers, and hospitals & clinics.

Get more detailed insights about Infusion System Market Research Report- Forecast To 2032

Regional Insights

Key Companies in the Infusion Systems Market market include

Industry Developments

Q2 2024: New platform creation exploded in 2024 with 11 announced platform deals, which was significantly more than in 2023 and 2022 combined. The infusion therapy sector saw a record number of platform M&A deals in 2024, with 11 new platforms announced, indicating increased consolidation and future add-on acquisition activity in the infusion system market.
Q2 2024: By far the largest acquirer in terms of announced deals since 2019 is publicly-traded Option Care, with eight. Option Care emerged as the most active acquirer in the infusion therapy market, having completed eight announced deals since 2019, with significant activity continuing into 2024.

Future Outlook

Infusion Systems Market Future Outlook

The Global Infusion System Market is projected to grow at a 10.55% CAGR from 2024 to 2032, driven by technological advancements, increasing chronic diseases, and rising healthcare expenditure.

New opportunities lie in:

Develop smart infusion systems integrating IoT for real-time monitoring and data analytics.
Expand into emerging markets with tailored infusion solutions addressing local healthcare needs.
Invest in R&D for innovative drug delivery methods enhancing patient compliance and outcomes.

By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in healthcare technology.

Market Segmentation

Infusion System Region Outlook

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe (RoE)
Asia Pacific
Japan
China
India
Rest of Asia Pacific (RoAPAC)
Latin America
Brazil
Mexico
Rest of Latin America (RoLA)
Middle East & Africa

Infusion System Product Outlook

Volumetric Infusion Pumps
Insulin Infusion Pumps
Enteral Infusion Pumps
Syringe Infusion Pumps
Ambulatory Infusion Pumps
PCA Pumps
Implantable Infusion Pumps
Infusion Catheters
IV/Administration Sets
Needleless Connectors
Cannulas
Tubing & Extension Sets
Valves
Devices
Disposable Infusion Pumps
Chemotherapy Infusion Pumps
Traditional Infusion Pumps
Specialty Infusion Pumps

Infusion System Application Outlook

Chemotherapy/Oncology
Diabetes
Gastroenterology
Analgesia/Pain Management
Pediatrics/Neonatology
Hematology
Other Applications

Report Scope

Attribute/Metric	Details
Market Size 2022	N/A (USD Billion)
Market Size 2023	N/A (USD Billion)
Market Size 2032	12.81 (USD Billion)
Compound Annual Growth Rate (CAGR)	8.9 % (2024- 2032)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2023
Market Forecast Period	2023 - 2032
Historical Data	2018-2022
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	3M, B. BRAUN MELSUNGEN AG, Baxter, Becton, Dickinson and Company, Fresenius Kabi AG, ICU Medical, Inc, Smiths Medical, and Terumo Medical Corporation
Key Market Opportunities	Joint ventures, strategic alliances, mergers and acquisitions, new product developments
Key Market Drivers	· Rising prevalence of chronic and fatal diseases · high demand of the infusion systems in the military medical units

Market Highlights

Author

Kinjoll Dey

Research Analyst Level I

She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Latest Comments

John Doe

john@example.com

This is a great article! Really helped me understand the topic better.

Posted on July 23, 2025, 10:15 AM

Jane Smith

jane@domain.com

Thanks for sharing this. I’ve bookmarked it for later reference.

Posted on July 22, 2025, 7:45 PM

View All

FAQs

What is the valuation of the global infusion systems market?

The global infusion systems market valuation is expected at USD 12.81 Millionby 2032.

What is the expected growth rate of the global infusion systems market?

The global infusion systems market is expected to grow at 8.9% CAGR from 2023-2032.

What are the main growth drivers of the global infusion systems market?

Technological breakthroughs from market leaders, demand of infusion units in the military, and prevalence of chronic diseases are major drivers of the global infusion systems market.

What are challenges facing the global infusion systems market?

Unmet medical needs in low-income countries and concerns regarding infusion are major challenges of the global infusion systems market.

Which region will dominate the global infusions systems market?

North America will dominate the global infusion systems market and will fetch close to USD 15.79 billion by 2025.

Which region can generate revenue the fastest in the global infusion systems market?

APAC is predicted to generate the fastest revenue for the global infusion systems market at a CAGR of 8.90% from 2022 to 2030.

Name the leaders of the global infusion systems market.

Terumo Medical Corporation, Becton, Dickinson and Company, ICU Medical, Inc, Fresenius Kabi AG, Smiths Medical, B. BRAUN MELSUNGEN AG, 3M, and Baxter are major players of the global infusion systems market.

Report Prologue
Market Introduction
1. Definition
2. Scope of Study
3. Research Objective
4. Assumptions & Limitations
  1. Assumptions
  2. Limitations
5. Market Structure
Research Methodology
1. Research Process
2. Primary Research
3. Secondary Research
4. Market Size Estimation
5. Forecast Model
Market Dynamics
1. Introduction
2. Drivers
  1. Increased Use of Infusion Pumps for the Delivery of Drugs and Other Fluids.
  2. Rising Prevalence of Chronic and Fatal Diseases
  3. High Demand of the Infusion Systems in the Military Medical Units.
  4. Technological Advancements from the Leading Market Players
3. Restraint
  1. Patient Safety Concerns and Improper Infusion Leading to the Severe Consequences.
  2. Unmet Medical Needs in the Low Income Countries
4. Opportunity
  1. Growing Geriatric Population Presents Significant Growth Opportunity
  2. Low Income Economies and Developing Nations With Improving Healthcare Facilities Present a Great Opportunity.
5. Macroeconomic Indicators
6. Mega Trends
Market Factor Analysis
1. Value Chain Analysis
  1. Research & Product Development
  2. Component Manufacturing
  3. Assembly
  4. Distribution
2. Porters Five Forces Model
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
3. Demand,Supply, and Gap Analysis
  1. Demand Side Factors
  2. Supply Side Factors
  3. Gap Closing Strategies
4. Pricing Analysis
5. Investment Opportunities
6. Merger & Acquisition Landscape
7. Upcoming Trends
Infusion System Market, By Product Type
1. Introduction
2. IV Disposable
3. Infusion Pump
  1. Volumetric Pump
  2. Ambulatory Pump
  3. Syringe Pump
Infusion System Market, By Application
1. Introduction
2. Chemotherapy
3. Diabetes
4. Gastrointestinal Disorders
5. Pediatrics
6. Other Applications
Infusion System Market, By End User
1. Introduction
2. Hospitals
3. Specialty Oncology Wards
4. Homecare
Global Infusion System Market, By Region
1. Introduction
2. North America
Infusion System Market, By Product Type
Infusion System Market, By Application
Infusion System Market, By End User
1. Introduction
  1. US
  2. Canada
Infusion System Market, By Product Type
Infusion System Market, By Application
Infusion System Market, By End User
1. Europe
Infusion System Market, By Application
1. Introduction
  1. Germany
Infusion System Market, By Application
1. France
  1. UK
Infusion System Market, By Product Type
Infusion System Market, By End User
1. Italy
  1. Spain
  2. Rest Of Western Europe
  3. EASTERN EUROPE
2. Asia-Pacific
  1. Introduction
  2. Japan
  3. China
  4. India
  5. REPUBLIC OF KOREA
  6. Australia
  7. Rest of Asia-Pacific
3. Middle East & Africa
Infusion System Market, By Product Type
Infusion System Market, By End User
1. Introduction
  1. Middle East
  2. Africa
Company Landscape
1. Company Share Analysis
2. Competitive Landscape
  1. Product Launch/Development
  2. Partnerships & Collaborations
  3. Acquisition
3. Current Market Driving Player & Their Strategies
Company Profile
1. 3M
  1. Overview
  2. Product Overview
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
2. Baxter
  1. Company Overview
  2. Product/Business Segment Overview
  3. Financial Overview
  4. Key Development
  5. SWOT Analysis
3. Becton, Dickinson and Company
  1. Overview
  2. Product/Business Segment Overview
  3. Financial Updates
  4. Key Developments
  5. SWOT Analysis
4. B. Braun Melsungen AG
  1. Overview
  2. Product/Business Segment Overview
  3. Financial Overview
  4. Key Development
  5. SWOT Analysis
5. Fresenius Kabi AG
  1. Company Overview
  2. Product/Business Segment Overview
  3. Financial Overview
  4. Key Development
  5. SWOT Analysis
6. ICU Medical, Inc
  1. Company overview
  2. Product Overview
  3. Financials
  4. Key Developments
  5. SWOT Analysis
7. Smiths Medical
  1. Company Overview
  2. Product Overview
  3. Financial Overview
  4. Key Developments
  5. S.W.O.T
8. Terumo Medical Corporation
  1. Company Overview
  2. Product Overview
  3. Financial Overview
  4. Key Developments
  5. SWOT Analysis
9. NIPRO Medical Corporation
  1. Company overview
  2. Product Overview
  3. Financials
  4. Key Developments
  5. SWOT Analysis
10. Zyno Medical
  1. Company Overview
  2. Product Overview
  3. Financials
  4. Key Developments
  5. SWOT Analysis
Conclusion
1. Key Findings
  1. CEO’s Viewpoint
  2. Unmet Needs
  3. Key Companies to Watch
  4. Prediction
Appendix
1. Discussion Blue Print
2. References
List of Tables and Figures
1. 14 List of Tables
2. TABLE 1 GROWTH DRIVERS: IMPACT ANALYSIS 25
3. TABLE 2 PRICING RANGE OF PUMPS 35
4. TABLE 3 GLOBAL INFUSION SYSTEM MARKET BY PRODUCT TYPE, 2020-2027 (USD MILLION) 41
5. TABLE 4 GLOBAL INFUSION SYSTEM IV DISPOSABLE MARKET BY REGION, 2020-2027 (USD MILLION) 42
6. TABLE 5 GLOBAL INFUSION PUMP MARKET BY REGION, 2020-2027 (USD MILLION) 44
7. TABLE 6 GLOBAL INFUSION SYSTEM MARKET BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 44
8. TABLE 7 GLOBAL VOLUMETRIC PUMP MARKET BY REGION, 2020-2027 (USD MILLION) 45
9. TABLE 8 GLOBAL AMBULATORY PUMP MARKET BY REGION, 2020-2027 (USD MILLION) 45
10. TABLE 9 GLOBAL SYRINGE PUMP MARKET BY REGION, 2020-2027 (USD MILLION) 46
11. TABLE 10 GLOBAL IV DISPOSABLE MARKET BY APPLICATION, 2020-2027 (USD MILLION) 48
12. TABLE 11 GLOBAL INFUSION PUMP MARKET BY APPLICATION, 2020-2027 (USD MILLION) 49
13. TABLE 12 GLOBAL IV DISPOSABLE MARKET FOR CHEMOTHERAPY BY REGION, 2020-2027 (USD MILLION) 50
14. TABLE 13 GLOBAL INFUSION PUMP MARKET BY CHEMOTHERAPY BY REGION, 2020-2027 (USD MILLION) 51
15. TABLE 14 GLOBAL IV DISPOSABLE MARKET FOR DIABETES BY REGION, 2020-2027 (USD MILLION) 52
16. TABLE 15 GLOBAL INFUSION PUMP MARKET BY DIABETES BY REGION, 2020-2027 (USD MILLION) 52
17. TABLE 16 GLOBAL IV DISPOSABLE MARKET FOR GASTROINTESTINAL DISEASES BY REGION, 2020-2027 (USD MILLION) 53
18. TABLE 17 GLOBAL INFUSION PUMP MARKET BY GASTROINTESTINAL DISEASES BY REGION, 2020-2027 (USD MILLION) 54
19. TABLE 18 GLOBAL IV DISPOSABLE MARKET FOR PEDIATRICS BY REGION, 2020-2027 (USD MILLION) 55
20. TABLE 19 GLOBAL INFUSION PUMP MARKET BY PEDIATRICS BY REGION, 2020-2027 (USD MILLION) 55
21. TABLE 20 GLOBAL INFUSION SYSTEM MARKET BY END USER, 2020-2027 (USD MILLION) 57
22. TABLE 21 GLOBAL INFUSION SYSTEM MARKET FOR HOSPITALS BY REGION, 2020-2027 (USD MILLION) 58
23. TABLE 22 GLOBAL INFUSION SYSTEM MARKET FOR SPECIALTY ONCOLOGY WARDS BY REGION, 2020-2027 (USD MILLION) 59
24. TABLE 23 GLOBAL INFUSION SYSTEM MARKET FOR HOMECARE BY REGION, 2020-2027 (USD MILLION) 60
25. TABLE 24 GLOBAL INFUSION SYSTEM MARKET, BY REGION, 2020-2027 (USD MILLION) 62
26. TABLE 25 NORTH AMERICA INFUSION SYSTEM MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 64
27. TABLE 26 NORTH AMERICA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 64
28. TABLE 27 NORTH AMERICA INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 65
29. TABLE 28 NORTH AMERICA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 65
30. TABLE 29 NORTH AMERICA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 66
31. TABLE 30 NORTH AMERICA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 66
32. TABLE 31 US INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 67
33. TABLE 32 US INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 67
34. TABLE 33 US IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 68
35. TABLE 34 US INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 68
36. TABLE 35 US INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 69
37. TABLE 36 CANADA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 69
38. TABLE 37 CANADA INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 70
39. TABLE 38 CANADA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 70
40. TABLE 39 CANADA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 71
41. TABLE 40 CANADA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 71
42. TABLE 41 EUROPE INFUSION SYSTEM MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 73
43. TABLE 42 EUROPE INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 74
44. TABLE 43 EUROPE IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 74
45. TABLE 44 EUROPE INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 75
46. TABLE 45 EUROPE INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 75
47. TABLE 46 GERMANY INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 76
48. TABLE 47 GERMANY IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 76
49. TABLE 48 GERMANY INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 77
50. TABLE 49 GERMANY INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 77
51. TABLE 50 FRANCE INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 78
52. TABLE 51 FRANCE IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 78
53. TABLE 52 FRANCE INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 78
54. TABLE 53 FRANCE INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 79
55. TABLE 54 UK INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 80
56. TABLE 55 UK IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 80
57. TABLE 56 UK INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 81
58. TABLE 57 UK INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 81
59. TABLE 58 ITALY INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 82
60. TABLE 59 ITALY IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 82
61. TABLE 60 ITALY INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 83
62. TABLE 61 ITALY INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 83
63. TABLE 62 SPAIN INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 84
64. TABLE 63 SPAIN IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 84
65. TABLE 64 SPAIN INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 85
66. TABLE 65 SPAIN INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 85
67. TABLE 66 REST OF WESTERN EUROPE INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 86
68. TABLE 67 REST OF WESTERN EUROPE IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 86
69. TABLE 68 REST OF WESTERN EUROPE INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 87
70. TABLE 69 REST OF WESTERN EUROPE INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 87
71. TABLE 70 EASTERN EUROPE INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 88
72. TABLE 71 EASTERN EUROPE IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 88
73. TABLE 72 EASTERN EUROPE INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 89
74. TABLE 73 EASTERN EUROPE INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 89
75. TABLE 74 ASIA-PACIFIC INFUSION SYSTEM MARKET SHARE BY COUNTRY, 2020 (%) 90
76. TABLE 75 ASIA-PACIFIC INFUSION SYSTEM MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 91
77. TABLE 76 ASIA-PACIFIC INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 91
78. TABLE 77 ASIA PACIFIC INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 92
79. TABLE 78 ASIA-PACIFIC IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 92
80. TABLE 79 ASIA-PACIFIC INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 93
81. TABLE 80 ASIA-PACIFIC INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 93
82. TABLE 81 JAPAN INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 94
83. TABLE 82 JAPAN INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 94
84. TABLE 83 JAPAN IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 95
85. TABLE 84 JAPAN INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 95
86. TABLE 85 JAPAN INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 96
87. TABLE 86 CHINA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 96
88. TABLE 87 CHINA INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 97
89. TABLE 88 CHINA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 97
90. TABLE 89 CHINA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 98
91. TABLE 90 CHINA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 98
92. TABLE 91 INDIA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 99
93. TABLE 92 INDIA INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 99
94. TABLE 93 INDIA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 100
95. TABLE 94 INDIA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 100
96. TABLE 95 INDIA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 101
97. TABLE 96 REPUBLIC OF KOREA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 101
98. TABLE 97 REPUBLIC OF KOREA INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 102
99. TABLE 98 REPUBLIC OF KOREA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 102
100. TABLE 99 REPUBLIC OF KOREA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 103
101. TABLE 100 REPUBLIC OF KOREA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 103
102. TABLE 101 AUSTRALIA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 104
103. TABLE 102 AUSTRALIA INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 104
104. TABLE 103 AUSTRALIA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 105
105. TABLE 104 AUSTRALIA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 105
106. TABLE 105 AUSTRALIA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 106
107. TABLE 106 REST OF ASIA-PACIFIC INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 106
108. TABLE 107 ROA INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 107
109. TABLE 108 REST OF ASIA-PACIFIC IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 107
110. TABLE 109 REST OF ASIA-PACIFIC INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 108
111. TABLE 110 REST OF ASIA-PACIFIC INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 108
112. TABLE 111 MIDDLE EAST & AFRICA INFUSION SYSTEM MARKET, BY REGION, 2020-2027 (USD MILLION) 109
113. TABLE 112 MIDDLE EAST & AFRICA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 110
114. TABLE 113 MIDDLE EAST & AFRICA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 110
115. TABLE 114 MIDDLE EAST & AFRICA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 111
116. TABLE 115 MIDDLE EAST & AFRICA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 111
117. TABLE 116 MIDDLE EAST INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 112
118. TABLE 117 MIDDLE EAST IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 112
119. TABLE 118 MIDDLE EAST INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 113
120. TABLE 119 MIDDLE EAST INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 113
121. TABLE 120 AFRICA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 114
122. TABLE 121 AFRICA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 114
123. TABLE 122 AFRICA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 115
124. TABLE 123 AFRICA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 115
125. TABLE 124 BAXTER: KEY DEVELOPMENT 130
126. TABLE 125 BRAUN MELSUNGEN AG: KEY DEVELOPMENT 137
127. TABLE 126 FRESENIUS KABI AG: KEY DEVELOPMENT 141 15 List of Figures
128. FIGURE 1 GLOBAL INFUSION SYSTEM MARKET SHARE, BY PRODUCT TYPE, 2020 (%) 13
129. FIGURE 2 GLOBAL IV DISPOSABLE MARKET SHARE, BY APPLICAION, 2020 (%) 14
130. FIGURE 3 GLOBAL INFUSION PUMP MARKET SHARE, BY APPLICAION, 2020 (%) 14
131. FIGURE 4 GLOBAL INFUSION SYSTEM MARKET SHARE, BY END USER, 2020 (%) 15
132. FIGURE 5 GLOBAL INFUSION SYSTEM MARKET SHARE, BY REGION, 2020 (%) 16
133. FIGURE 1 MARKET STRUCTURE OF GLOBAL INFUSION SYSTEM MARKET 18
134. FIGURE 2 RESEARCH PROCESS 19
135. FIGURE 3 GLOBAL INFUSION SYSTEM MARKET: MARKET DYNAMICS 22
136. FIGURE 4 VALUE CHAIN: INFUSION SYSTEM DENTAL IMAGING MARKET 30
137. FIGURE 5 PORTERS FIVE FORCES MODEL 31
138. FIGURE 6 GLOBAL INFUSION SYSTEM MARKET SHARE BY PRODUCT TYPE, 2020 (%) 40
139. FIGURE 7 GLOBAL IV DISPOSABLE MARKET SHARE BY APPLICATION, 2020 (%) 47
140. FIGURE 8 GLOBAL INFUSION PUMP MARKET SHARE BY APPLICATION, 2020 (%) 48
141. FIGURE 9 GLOBAL INFUSION SYSTEM MARKET SHARE BY END USER, 2020 (%) 57
142. FIGURE 10 GLOBAL INFUSION SYSTEM MARKET SHARE, BY REGION, 2020 (%) 61
143. FIGURE 11 NORTH AMERICA INFUSION SYSTEM MARKET SHARE BY COUNTRY, 2020 (%) 63
144. FIGURE 12 EUROPE INFUSION SYSTEM MARKET SHARE BY COUNTRY, 2020 (%) 73
145. FIGURE 13 MIDDLE EAST & AFRICA INFUSION SYSTEM MARKET SHARE BY REGION, 2020 (%) 109
146. FIGURE 14 GLOBAL INFUSION SYSTEM COMPANY SHARE ANALYSIS, 2020 (%) 116
147. FIGURE 15 3M: RECENT FINANCIALS 124
148. FIGURE 16 3M: SEGMENTAL REVENUE 124
149. FIGURE 17 3M: GEOGRAPHICAL REVENUE 125
150. FIGURE 18 3M: SWOT ANALYSIS 126
151. FIGURE 19 BAXTER: RECENT FINANCIAL 128
152. FIGURE 20 BAXTER: HISTORICAL SEGMENTAL REVENUE (USD MILLION) 128
153. FIGURE 21 BAXTER: GEOGRAPHICAL MIX 129
154. FIGURE 22 BAXTER: OPERATING SEGMENTS 129
155. TABLE 124 BAXTER 130
156. FIGURE 23 BAXTER: SWOT ANALYSIS 130
157. FIGURE 24 BECTON, DICKINSON AND COMPANY: FINANCIAL REVENUE 132
158. FIGURE 25 BECTON, DICKINSON AND COMPANY: HISTORICAL SEGMENTAL REVENUE (USD MILLION) 132
159. FIGURE 26 BECTON, DICKINSON AND COMPANY: SEGMENTAL REVENUE 133
160. FIGURE 27 BECTON, DICKINSON AND COMPANY: GEOGRAPHICAL REVENUE 133
161. FIGURE 28 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS 134
162. FIGURE 29 BRAUN MELSUNGEN AG: RECENT FINANCIALS 136
163. FIGURE 30 BRAUN MELSUNGEN AG: HISTORICAL SEGMENTAL REVENUE (USD MILLION) 136
164. FIGURE 31 BRAUN MELSUNGEN AG: BUSINESS REVENUE 137
165. FIGURE 32 BRAUN MELSUNGEN AG: GEOGRAPHICAL REVENUE 137
166. TABLE 125 BRAUN MELSUNGEN AG 137
167. FIGURE 33 BRAUN MELSUNGEN AG: SWOT ANALYSIS 138
168. FIGURE 34 FRESENIUS KABI AG: RECENT FINANCIAL 139
169. FIGURE 35 FRESENIUS KABI AG: HISTORICAL SEGMENTAL REVENUE (USD MILLION) 140
170. FIGURE 36 FRESENIUS KABI AG: GEOGRAPHICAL MIX 140
171. FIGURE 37 FRESENIUS KABI AG: OPERATING SEGMENTS 141
172. FIGURE 38 FRESENIUS KABI AG: SWOT ANALYSIS 142
173. FIGURE 39 ICU MEDICAL, INC: RECENT FINANCIALS 143
174. FIGURE 40 ICU MEDICAL, INC: HISTORICAL SEGMENTAL REVENUE (USD MILLION) 144
175. FIGURE 41 ICU MEDICAL, INC: GEOGRAPHICAL MIX, 2020 (%) 144
176. FIGURE 42 ICU MEDICAL, INC: SEGMENTAL MIX, 2020 (%) 145
177. FIGURE 43 ICU MEDICAL, INC: SWOT ANALYSIS 146
178. FIGURE 44 SMITH’S MEDICAL: HISTORICAL REVENUE 148
179. FIGURE 45 SMITH’S MEDICAL: HISTORICAL SEGMENTAL REVENUE (USD MILLION) 148
180. FIGURE 46 SMITH’S MEDICAL: SEGMENT MIX, 2020 (%) 149
181. FIGURE 47 TERUMO MEDICAL CORPORATION FINANCIAL OVERVIEW: REVENUE & RND (%) 152
182. FIGURE 48 TERUMO MEDICAL CORPORATION HISTORICAL SEGMENTAL REVENUE (USD MILLION) 152
183. FIGURE 49 TERUMO MEDICAL CORPORATION FINANCIAL OVERVIEW SEGMENTAL OVERVIEW 153
184. FIGURE 50 TERUMO MEDICAL CORPORATION FINANCIAL OVERVIEW GEOGRAPHICAL OVERVIEW 153
185. FIGURE 51 TERUMO: SWOT ANALYSIS 154
186. FIGURE 52 NIPRO MEDICAL CORPORATION: FINANCIAL INFORMATION 156
187. FIGURE 53 NIPRO MEDICAL CORPORATION: GEOGRAPHICAL MIX, 2020 (%) 156
188. FIGURE 54 NIPRO MEDICAL CORPORATION: SEGMENTAL MIX, 2020 (%) 157
189. FIGURE 55 NIPRO MEDICAL CORPORATION: MEDICAL RELATED – PRODUCT MIX 157
190. FIGURE 56 NIPRO MEDICAL CORPORATION: SWOT ANALYSIS 159
191. FIGURE 57 ZYNO MEDICAL: SWOT ANALYSIS 162

Infusion System Market Segmentation

Market Segmentation Overview

Detailed segmentation data will be available in the full report
Comprehensive analysis by multiple parameters
Regional and country-level breakdowns
Market size forecasts by segment

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027